TRANSPLANTE RENAL: AVANÇOS, DESAFIOS E RESULTADOS A LONGO PRAZO: REVISÃO INTEGRATIVA

Authors

  • Eliab Batista Barros Universidade Federal de Alagoas
  • Claudia Holanda Ribeiro Universidade Federal do Amazonas
  • Icaro Rodrigues Mendes Pedrosa Pinto Faculdade de Medicina Estacio de Juazeiro do Norte
  • Pedro Gabriel Araujo Pereira Itapary Universidade Federal do Piauí
  • Lovily Duarte Toledo Paiva Centro Universitário de Caratinga
  • Vytoria Rodrigues Moura UNIFACID
  • Alessandro Henrique de Sousa Oliveira Altino Universidade Federal do Piauí
  • Alex Fabiano Sousa Barreto Universidade Federal do Maranhão
  • Sâmia Moura Araújo Centro Universitário Uninovafapi
  • Felipe Martins de Carvalho Centro Universitário Uninovafapi
  • Raphael Augusto Gir de Carvalho Faculdade de Medicina de Jundiaí - FMJ

DOI:

https://doi.org/10.36557/pbpc.v3i2.180

Keywords:

Kidney Transplant, Therapies, Advances.

Abstract

Introduction: Kidney transplantation represents one of the greatest advances in modern medicine, being considered the treatment of choice for patients with end-stage chronic renal failure.

Methodology: To collect data, a systematic search was carried out in the main scientific databases, including PubMed, Scopus, Web of Science and SciELO. The keywords used in the search were "kidney transplant", "advances in kidney transplantation", "kidney transplant challenges", "long-term results in kidney transplantation", "immunosuppression", "chronic rejection" and "quality of life post-transplant".

Result: Advances in immunosuppressive therapy are one of the pillars of successful kidney transplantation. The introduction of medications such as cyclosporine in the 1980s revolutionized transplant management, drastically reducing acute rejection rates.

Conclusion: In conclusion, kidney transplantation continues to be a life-saving intervention and significantly improves the quality of life of patients with chronic renal failure.

Downloads

Download data is not yet available.

References

Neuberger JM, Bechstein WO, Kuypers DR, Burra P, Citterio F, De Geest S, et al. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Transplantation. 2017;101(4S Suppl 2):S1-S56. doi: https://doi.org/10.1097/TP.0000000000001651

Gouveia DS, Bignelli AT, Hokazono SR, Danucalov I, Siemens TA, Meyer F, et al. Analysis of economic impact between the modality of renal replacement therapy. Braz J Nephrol.2017;39(2):162–71. doi: https://doi.org/10.5935/0101-2800.20170019

Strohmaier S, Wallisch C, Kammer M, et al. Survival Benefit of First Single-Organ Deceased Donor Kidney Transplantation Compared With Long-term Dialysis Across Ages in Transplant-Eligible Patients With Kidney Failure. JAMA Netw Open. 2022;5(10):e2234971. doi: https://doi.org/10.1001/jamanetworkopen.2022.34971

McFarlane PA. Should patients remain on intensive hemodialysis rather than choosing to receive a kidney transplant?. Semin. Dial. 2010;23(5):516-519. doi: https://doi.org/10.1111/j.1525-139X.2010.00740.x

Manfro RC, Noronha IL, Silva Filho AP. Manual de Transplante Renal. 2. Ed. São Paulo: Editora Manole, 2014.

Hansen R, Seifeldin R, Noe L. Medication Adherence in chronic disease: issues in post transplant immunosuppression. Transplant Proc. 2007;39(5):1287-1300. doi: https://doi.org/10.1016/j.transproceed.2007.02.074.

Rebelo RN de S, Rodrigues CIS. Arterial hypertension in kidney transplantation: huge importance, but few answers. Braz J Nephrol. 2023;45(1):84–94. doi: https://doi.org/10.1590/2175-8239-JBN-2022-0109en

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180 (7): 934-43. doi: https://doi.org/10.1001/jamainternmed.2020.0994.

Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Lee SS. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. EurRev Med PharmacolSci. 2020;24(7):4016-4026. doi: https://doi.org/10.26355/eurrev_202004_20871

Raja MA, Mendoza MA, Villavicencio A, Anjan S, Reynolds JM, Kittipibul V,et al. COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature. Transplant Rev (Orlando). 2021;35(1):100588. doi: https://doi.org/10.1016/j.trre.2020.100588

Downloads

Published

2024-08-22

How to Cite

BARROS, Eliab Batista et al. TRANSPLANTE RENAL: AVANÇOS, DESAFIOS E RESULTADOS A LONGO PRAZO: REVISÃO INTEGRATIVA. Periódicos Brasil. Pesquisa Científica, Macapá, Brasil, v. 3, n. 2, p. 1394–1402, 2024. DOI: 10.36557/pbpc.v3i2.180. Disponível em: https://periodicosbrasil.emnuvens.com.br/revista/article/view/180. Acesso em: 27 sep. 2025.

Issue

Vol. 3 No. 2 (2024): PBPC 2024

Section

Ciências da Saúde

License

Copyright (c) 2024 Eliab Batista Barros, Claudia Holanda Ribeiro, Icaro Rodrigues Mendes Pedrosa Pinto, Pedro Gabriel Araujo Pereira Itapary, Lovily Duarte Toledo Paiva, Vytoria Rodrigues Moura, Alessandro Henrique de Sousa Oliveira Altino, Alex Fabiano Sousa Barreto, Sâmia Moura Araújo, Felipe Martins de Carvalho, Raphael Augusto Gir de Carvalho

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Você tem o direito de:

  1. Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
  2. Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
  3. O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.  

 

De acordo com os termos seguintes:

  1. Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
  2. Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.